-
Bio-Images-CPS Research partnership offers streamlined formulation route
28.08.2011A strategic partnership between two research organisations based in Glasgow, Scotland will combine formulation expertise with clinical trial capabilities to streamline the development and passage to market of new, enhanced drug formats.
прочети -
NICE final "no" for BM-S' Orencia in RA
28.08.2011The National Institute for Health and Clinical Excellence (NICE) has issued final guidance rejecting the use of Bristol-Myers Squibb's Orencia (abatacept) as a second-line treatment for rheumatoid arthritis (RA).
прочети -
Boehringer/Lilly's diabetes drug gets Europe OK
28.08.2011Boehringer Ingelheim and partner Eli Lilly are celebrating the news that regulators in Europe have given the green light to their once-daily type 2 diabetes pill Trajenta.
прочети -
Is GSK finally ready to move on Human Genome Sciences bid?
27.08.2011Now that shares of Human Genome Sciences ($HGSI) have been badly beaten up in recent months, the analysts at Piper Jaffray say they can smell a potential takeover bid from GlaxoSmithKline ($GSK).
прочети -
Sanofi to Buy Indian Nutraceutical Unit; Terms Not Disclosed
27.08.2011Sanofi agreed to buy a unit of India’s Universal Medicare Ltd. that makes branded health and nutrition treatments as the French drugmaker tries to increase sales from non-prescription products.
прочети -
US health agency revises conflict of interest rules
27.08.2011WASHINGTON, Aug 23 (Reuters) - The U.S. National Institutes of Health revised on Tuesday its 16-year-old conflict of interest rules for medical researchers, lowering the amount of money that constitutes a financial conflict and expanding the required disclosures.
прочети -
Investigations into the Nurofen Plus mix-up begin
27.08.2011Investigations are under way into how some packets of Nurofen Plus came to contain antipsychotic drugs.
прочети -
Shire battles back to win FDA OK for HAE drug Firazyr
27.08.2011Three years after dismissing an application for Firazyr (icatibant) after citing the company for insufficient trial data, regulators at the FDA this morning stamped Shire's ($SHPGY) new drug for hereditary angioedema with an approval.
прочети -
Stanford investigators match old drugs with new medical uses
22.08.2011A small crew of researchers at Stanford University School of Medicine has come up with an ingenious new method to screen a large slate of approved drugs for compounds that have the potential to be repurposed for use against other diseases as well.
прочети -
Researchers Show Gains in Finding Reusable Drugs
22.08.2011In a bit of high-tech recycling, researchers have developed an innovative way to identify already-approved drugs that may work against diseases they weren't designed to combat.
прочети
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961
